Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy to treat lymphedema and to improve reconstructive surgery

Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy to treat lymphedema and to improve reconstructive surgery

US Patent 8852936 · Granted Oct 7, 2014

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of protecting a solid organ transplant tissue with angiopoietin-2 antibo2019
Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis2018
Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy2016
Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis2015
Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy2015
Pharmaceutical compositions comprising a VEGF-D polypeptide2014
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof,2014
Method of enhancing the acceptance and/or healing of a skin graft2013
Use of VEGF-D gene to prevent restenosis2013
Methods of screening for neoplastic disease states2013
Methods of making VEGF-D polypeptides2013
Method of treatment for lymphedema comprising administering a polynucleotide enc2013